What programming languages like R and Python are to data science ... “controlled molecular generation of small molecules.” Recursion is also joining the party and will be the first third ...

The best way to make this happen is for Recursion to achieve success with its pipeline programs. Recursion has five candidates in phase 2 clinical studies. We won't have to wait long to learn how ...

Ph.D., Co-Founder and CEO of Recursion. “With more than 10 clinical and preclinical programs in the internal pipeline, more than 10 partnered programs and over $450M in upfront and realized ...

Mathematical Background: We expect that the student is comfortable with basic mathematics at the level of a U.S. first-year college STEM student. This includes basic notions such as sets and functions ...

Machine learning-powered drug discoverer Recursion Pharmaceuticals has secured $121 million in new financing for its artificial intelligence programs. The proceeds will help the former Fierce 15 ...

Success for just one of Recursion's phase 2 programs could enable the stock to double within five years. However, the odds of success for phase 2 candidates aren't good. Risk-averse investors ...